Education
About Us
Working with TipRanks
Follow Us
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
RESEARCH TOOLSreports
Total Valuation
Mankind Pharma Ltd. has a market cap or net worth of ₹1.09T. The enterprise value is ₹1.17T.
Market Cap₹1.09T
Enterprise Value₹1.17T
Share Statistics
Mankind Pharma Ltd. has 412,728,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding412,728,760
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mankind Pharma Ltd.’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 19.17%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)19.17%
Return on Capital Employed (ROCE)0.27
Revenue Per Employee6.25M
Profits Per Employee1.02M
Employee Count19,540
Asset Turnover0.44
Inventory Turnover1.67
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio53.8
PS Ratio0.00
PB Ratio7.57
Price to Fair Value6.96
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-19.13
Income Statement
In the last 12 months, Mankind Pharma Ltd. had revenue of 122.07B and earned 19.91B in profits. Earnings per share was 49.17.
Revenue122.07B
Gross Profit87.18B
Operating Income60.26B
Pretax Income25.16B
Net Income19.91B
EBITDA30.18B
Earnings Per Share (EPS)49.17
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Mankind Pharma Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.46
52-Week Price Change25.84%
50-Day Moving Average2.44K
200-Day Moving Average2.52K
Relative Strength Index (RSI)68.64
Average Volume (3m)27.49K
Important Dates
Mankind Pharma Ltd. upcoming earnings date is Jul 31, 2025, Before Open (Confirmed).
Last Earnings DateMay 21, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date―
Financial Position
Mankind Pharma Ltd. as a current ratio of 1.23, with Debt / Equity ratio of 59.39%
Current Ratio1.23
Quick Ratio0.86
Debt to Market Cap0.09
Net Debt to EBITDA2.64
Interest Coverage Ratio14.03
Taxes
In the past 12 months, Mankind Pharma Ltd. has paid 5.10B in taxes.
Income Tax5.10B
Effective Tax Rate0.20
Enterprise Valuation
Mankind Pharma Ltd. EV to EBITDA ratio is 35.67, with an EV/FCF ratio of 55.13.
EV to Sales8.82
EV to EBITDA35.67
EV to Free Cash Flow55.13
EV to Operating Cash Flow44.61
Balance Sheet
Mankind Pharma Ltd. has ₹22.45B in cash and marketable securities with ₹85.11B in debt, giving a net cash position of ₹62.66B billion.
Cash & Marketable Securities₹22.45B
Total Debt₹85.11B
Net Cash₹62.66B
Net Cash Per Share₹151.82
Tangible Book Value Per Share-₹50.49
Margins
Gross margin is 59.35%, with operating margin of 49.36%, and net profit margin of 16.31%.
Gross Margin59.35%
Operating Margin49.36%
Pretax Margin20.61%
Net Profit Margin16.31%
EBITDA Margin24.72%
EBIT Margin19.63%
Analyst Forecast
The average price target for Mankind Pharma Ltd. is ₹2,683.33, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹2,683.33
Price Target Upside1.15% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast18.82%
EPS Growth Forecast3.35%